Orlistat delays hepatocarcinogenesis in mice with hepatic co-activation of AKT and c-Met
Cong Zhang, Lei Sheng, Ming Yuan, Junjie Hu, Yan Meng, Yong Wu, Liang Chen, Huifan Yu, Shan Li, Guohua Zheng, Zhenpeng Qiu
Topics & Concepts
OrlistatProtein kinase BCancer researchPI3K/AKT/mTOR pathwayLipogenesisIn vivoPTENHepatocellular carcinomaSteatosisHCCSPharmacologyMedicineInternal medicineChemistrySignal transductionBiologyBiochemistryLipid metabolismObesityWeight lossBiotechnologyCancer, Lipids, and MetabolismPeroxisome Proliferator-Activated ReceptorsCancer, Hypoxia, and Metabolism